Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.
San Francisco’s iconic Folsom Street Fair could soon see a high-profile departure:… Continue reading
As the supervisor of the Tenderloin and SoMa neighborhood, Matt Haney said… Continue reading
Savvy Nato Green and friends save comedy club from eviction
San Francisco’s sleepy West Side — from the Richmond District to Parkmerced… Continue reading
Supervisor working to give all current residents a chance to move into new development
